INCB-123667

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameINCB-123667
Drug Alias NameINCB-0123667INCB-123667
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 2 inhibitors
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsSolid tumoursRenal InsufficiencyHepatic Insufficiency +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[16] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesIncyte Corp
Inactive CompaniesN/A
Active IndicationsSolid tumoursRenal InsufficiencyHepatic Insufficiency +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A